HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Severe maternal morbidity and mortality from amniotic fluid embolism in the Netherlands.

Abstract
We have assessed the incidence, symptoms and risk factors of amniotic fluid embolism in the Netherlands. Data were retrieved from two nationwide registration systems. From 1983 to 2005 the maternal mortality ratio of amniotic fluid embolism increased from 0.11 to 0.63 (odds ratio (OR) 5.8, 95% confidence interval (CI) 1.3-25.3). The most common signs and symptoms of amniotic fluid embolism were dyspnea and massive obstetric hemorrhage. In the majority of women, onset of symptoms was intrapartum or immediately postpartum. Potential risk factors of developing amniotic fluid embolism were maternal age >30, multiparity (OR 3.3, 95% CI 1.02-10.5), cesarean section (OR 1.3, 95% CI 0.3-5.2) and induction of labor (OR 2.1, 95% CI 2.1-6.1). Perinatal mortality was increased to 38.1% compared with 0.98% in the general pregnant population (p < 0.001) High maternal age and multiparity are the most important risk factors for developing amniotic fluid embolism.
AuthorsKoen H Stolk, Joost J Zwart, Joke Schutte, Jos VAN Roosmalen
JournalActa obstetricia et gynecologica Scandinavica (Acta Obstet Gynecol Scand) Vol. 91 Issue 8 Pg. 991-5 (Aug 2012) ISSN: 1600-0412 [Electronic] United States
PMID22568783 (Publication Type: Journal Article)
Copyright© 2012 The Authors Acta Obstetricia et Gynecologica Scandinavica© 2012 Nordic Federation of Societies of Obstetrics and Gynecology.
Topics
  • Adult
  • Age Factors
  • Cesarean Section
  • Embolism, Amniotic Fluid (diagnosis, epidemiology, etiology, mortality)
  • Female
  • Gestational Age
  • Humans
  • Incidence
  • Labor, Induced
  • Maternal Age
  • Maternal Mortality
  • Morbidity
  • Netherlands (epidemiology)
  • Odds Ratio
  • Parity
  • Pregnancy
  • Registries
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: